Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody

被引:50
|
作者
Malaviya, Rama [1 ]
Sunil, Vasanthi R. [1 ]
Venosa, Alessandro [1 ]
Verissimo, Vivianne L. [1 ]
Cervelli, Jessica A. [1 ]
Vayas, Kinal N. [1 ]
Hall, LeRoy [3 ]
Laskin, Jeffrey D. [2 ]
Laskin, Debra L. [1 ]
机构
[1] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Environm & Occupat Med, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[3] Janssen Res & Dev, Dept Drug Safety Sci, Raritan, NJ 08869 USA
基金
美国国家卫生研究院;
关键词
alveolar macrophages; lung injury; vesicant; fibrosis; ACUTE LUNG INJURY; SULFUR MUSTARD; MACROPHAGE ACTIVATION; TISSUE-INJURY; MURINE MODEL; TNF-ALPHA; INFLAMMATION; EXPRESSION; MECHANISMS; RECEPTOR;
D O I
10.1093/toxsci/kfv161
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Nitrogen mustard (NM) is a bifunctional alkylating agent that causes acute injury to the lung that progresses to fibrosis. This is accompanied by a prominent infiltration of macrophages into the lung and upregulation of proinflammatory/profibrotic cytokines including tumor necrosis factor (TNF)alpha. In these studies, we analyzed the ability of anti-TNF alpha antibody to mitigate NM-induced lung injury, inflammation, and fibrosis. Treatment of rats with anti-TNF alpha antibody (15 mg/kg, iv, every 9 days) beginning 30 min after intratracheal administration of NM (0.125 mg/kg) reduced progressive histopathologic alterations in the lung including perivascular and peribronchial edema, macrophage/monocyte infiltration, interstitial thickening, bronchiolization of alveolar walls, fibrin deposition, emphysema, and fibrosis. NM-induced damage to the alveolar-epithelial barrier, measured by bronchoalveolar lavage (BAL) protein and cell content, was also reduced by anti-TNF alpha antibody, along with expression of the oxidative stress marker, heme oxygenase-1. Whereas the accumulation of proinflammatory/cytotoxic M1 macrophages in the lung in response to NM was suppressed by anti-TNF alpha antibody, antiinflammatory/profibrotic M2 macrophages were increased or unchanged. Treatment of rats with anti-TNF alpha antibody also reduced NM-induced increases in expression of the profibrotic mediator, transforming growth factor-beta. This was associated with a reduction in NM-induced collagen deposition in the lung. These data suggest that inhibiting TNF alpha may represent an efficacious approach to mitigating lung injury induced by mustards.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 50 条
  • [31] Anti-tumor necrosis factor-α is potentially better than tumor necrosis factor-α as the biomarker for sarcopenia: Results from the I-Lan longitudinal aging study
    Lin, Wei-Ju
    Lee, Wei-Ju
    Peng, Li-Ning
    Huang, Yi-Long
    Tung, Chien-Yi
    Lin, Chi-Hung
    Tsai, Ting-Fen
    Chen, Liang-Kung
    EXPERIMENTAL GERONTOLOGY, 2023, 172
  • [32] The differences in apoptosis and pulmonary fibrosis between sulfur mustard-induced acute pulmonary injury via intraperitoneal injection and Intratracheal instillation in rats
    Han, Wei
    Cui, Dong-Yan
    Yu, Dan
    Li, Yuan
    Zhao, Jian
    Liu, Fei
    Zhao, Yu-Ling
    Zhu, Xiao-Ji
    Zhong, Yu-Xu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (12): : 15974 - 15990
  • [33] The Effects of Interleukin-1β in Tumor Necrosis Factor-α-Induced Acute Pulmonary Inflammation in Mice
    Saperstein, Sara
    Huyck, Heidie
    Kimball, Elizabeth
    Johnston, Carl
    Finkelstein, Jacob
    Pryhuber, Gloria
    MEDIATORS OF INFLAMMATION, 2009, 2009
  • [34] Differential Expression of Nuclear Factor-κB Mediates Increased Pulmonary Expression of Tumor Necrosis Factor-α and Virus-Induced Asthma
    Uhl, Elizabeth W.
    Clarke, Tracy J.
    Hogan, Robert J.
    VIRAL IMMUNOLOGY, 2009, 22 (02) : 79 - 89
  • [35] Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease
    Loza, Matthew J.
    Watt, Rosemary
    Baribaud, Frederic
    Barnathan, Elliot S.
    Rennard, Stephen I.
    RESPIRATORY RESEARCH, 2012, 13
  • [36] The role of tumor necrosis factor-α in acetaminophen-induced liver injury in rats
    Zhan, Jun
    Zhang, Lei
    Wu, Bai-He
    Yu, Zhong
    Zhou, Hui-Min
    Chen, Mei-Zhu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 189 - 189
  • [37] Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
    Maeki-Petaejae, Kaisa M.
    Elkhawad, Maysoon
    Cheriyan, Joseph
    Joshi, Francis R.
    Oestoer, Andrew J. K.
    Hall, Frances C.
    Rudd, James H. F.
    Wilkinson, Ian B.
    CIRCULATION, 2012, 126 (21) : 2473 - 2480
  • [38] Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
    Yoo, In Kyung
    Choung, Rok Seon
    Hyun, Jong Jin
    Kim, Seung Young
    Jung, Sung Woo
    Koo, Ja Seol
    Lee, Sang Woo
    Choi, Jai Hyun
    Kim, Ho
    Lee, Hong Sik
    Keum, Bora
    Kim, Eun Sun
    Jeen, Yoon Tae
    YONSEI MEDICAL JOURNAL, 2014, 55 (02) : 442 - 448
  • [39] Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis
    Oberoi, Raghav
    Vlacil, Ann-Kathrin
    Schuett, Jutta
    Schoesser, Florian
    Schuett, Harald
    Tietge, Uwe J. F.
    Schieffer, Bernhard
    Grote, Karsten
    ATHEROSCLEROSIS, 2018, 277 : 80 - 89
  • [40] Immunohistochemical expression of tumor necrosis factor-α in sepsis-induced lung injury
    Tomoko Miyashita
    Nobuyuki Kakimoto
    Yuko Ishida
    Takahito Hayashi
    Akihiko Kimura
    Michael Tsokos
    Toshikazu Kondo
    Forensic Science, Medicine, and Pathology, 2006, 2 (2) : 103 - 108